• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,362
2,297
1,863
1,845
1,724

COUNTRY

872
646
269
253
211

CATEGORIES

  • 858
  • 187
  • 678
  • 1,126
    • 99
  • 389
  • 270
  • 252
  • 65
  • 378
  • 682
  • 1,319
  • 1,354
  • 625
  • 883
  • 1,690
  • 2,670
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 507
  • 730
  • 0
  • 93

PRICE

6,753
11,392
17,841
25,085

PUBLISHED

1,947
2,804
7,335
25,085

PRODUCT TYPE

20,964
2,901
870
164
74
44
21
21
19
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Pegasus Pharmaceuticals, Inc.,(PGUZ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Pegasus Pharmaceuticals, Inc.,(PGUZ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Pegasus Pharmaceuticals, Inc.,(PGUZ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Pegasus Pharmaceuticals, Inc. (PGUZ), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Metabasis Therapeutics Inc,(LGNZZ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Metabasis Therapeutics Inc,(LGNZZ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Metabasis Therapeutics Inc,(LGNZZ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Metabasis Therapeutics Inc (LGNZZ), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Methylgene Inc.,(MYG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Methylgene Inc.,(MYG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Methylgene Inc.,(MYG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Methylgene Inc. (MYG), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Neogen Corporation,(NEOG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Neogen Corporation,(NEOG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Neogen Corporation,(NEOG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Neogen Corporation (NEOG), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Neuralstem, Inc.,(CUR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Neuralstem, Inc.,(CUR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Neuralstem, Inc.,(CUR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Neuralstem, Inc. (CUR), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Neurobiological Technologies,(NTII) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Neurobiological Technologies,(NTII) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Neurobiological Technologies,(NTII) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Neurobiological Technologies (NTII), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Novartis AG,(NVS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Novartis AG,(NVS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Novartis AG,(NVS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Novartis AG (NVS), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Novo-Nordisk AS,(NVO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Novo-Nordisk AS,(NVO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Novo-Nordisk AS,(NVO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Novo-Nordisk AS (NVO), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Onyx Pharmaceuticals Inc,(ONXX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Onyx Pharmaceuticals Inc,(ONXX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Onyx Pharmaceuticals Inc,(ONXX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Onyx Pharmaceuticals Inc (ONXX), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Pharmacyclics Inc,(PCYC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Pharmacyclics Inc,(PCYC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Pharmacyclics Inc,(PCYC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Pharmacyclics Inc (PCYC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Bioqual Inc.,(BIOQ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Bioqual Inc.,(BIOQ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Bioqual Inc.,(BIOQ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Bioqual Inc. (BIOQ), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
BioSpecifics Technologies Corporation,(BSTC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages BioSpecifics Technologies Corporation,(BSTC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

BioSpecifics Technologies Corporation,(BSTC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for BioSpecifics Technologies Corporation (BSTC), plus vital industry benchmarks and extensive operating ratios,...

October 2013
FROM
Cannabis Science Inc.,(CBIS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Cannabis Science Inc.,(CBIS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Cannabis Science Inc.,(CBIS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Cannabis Science Inc. (CBIS), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Capstone Therapeutics Corp,(CAPS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Capstone Therapeutics Corp,(CAPS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Capstone Therapeutics Corp,(CAPS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Capstone Therapeutics Corp (CAPS), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Changyu Medtech Ltd.,(CYQ.H) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Changyu Medtech Ltd.,(CYQ.H) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Changyu Medtech Ltd.,(CYQ.H) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Changyu Medtech Ltd. (CYQ.H), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Chembio Diagnostics Inc,(CEMI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Chembio Diagnostics Inc,(CEMI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Chembio Diagnostics Inc,(CEMI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Chembio Diagnostics Inc (CEMI), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Curis Inc,(CRIS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Curis Inc,(CRIS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Curis Inc,(CRIS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Curis Inc (CRIS), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

October 2013
FROM
22nd Century Group, Inc.,(XXII) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages 22nd Century Group, Inc.,(XXII) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

22nd Century Group, Inc.,(XXII) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for 22nd Century Group, Inc. (XXII), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
AcelRx Pharmaceuticals, Inc.,(ACRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages AcelRx Pharmaceuticals, Inc.,(ACRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

AcelRx Pharmaceuticals, Inc.,(ACRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AcelRx Pharmaceuticals, Inc. (ACRX), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Acorda Therapeutics Inc,(ACOR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Acorda Therapeutics Inc,(ACOR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Acorda Therapeutics Inc,(ACOR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Acorda Therapeutics Inc (ACOR), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Loading Indicator

Our Clients

Our clients' logos